grey market peptides retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Vial of unapproved peptide retatrutide

As a distance runner, Carly Anderson may be setting the pace for the future of GLPs

The GLP-1 Support Premium Patch Pack is the ultimate solution for individuals seeking enhanced support during their GLP-1 therapy

Food and Drug Administration sent warning letters Tuesday to 30 telehealth companies regarding the online sale and promotion of compounded GLP-1 drugs, including semaglutide and tirzepatide

Cardiologists treating patients with atherosclerotic cardiovascular disease are increasingly initiating semaglutide as a cardiovascular risk modifier, adding an estimated 4.8 million new commercial GLP-1 patients annually